Reckitt Benckiser Group (LON:RKT) Rating Reiterated by HSBC

Reckitt Benckiser Group (LON:RKT)‘s stock had its “hold” rating reaffirmed by analysts at HSBC in a research report issued to clients and investors on Thursday, Marketbeat.com reports.

Reckitt Benckiser Group Trading Up 0.7 %

LON RKT opened at GBX 4,167 ($51.87) on Thursday. Reckitt Benckiser Group has a 12 month low of GBX 4,102.64 ($51.07) and a 12 month high of GBX 6,570 ($81.79). The company has a 50-day moving average of GBX 4,863.91 and a 200-day moving average of GBX 5,325.61. The company has a debt-to-equity ratio of 100.80, a current ratio of 0.64 and a quick ratio of 0.46. The company has a market cap of £29.52 billion, a P/E ratio of 1,835.68, a P/E/G ratio of 3.76 and a beta of 0.07.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.